News / Taimour Khalid - 3 years ago
Gates Foundation Pledges $120Mln for Supply of New US COVID-19 Drug in ..
The Bill and Melinda Gates Foundation has announced the allocation of up to $120 million to facilitate access for lower-income countries to molnupiravir, an experimental coronavirus drug being developed by US pharmaceutical company Merck & Co in collaboration with Ridgeback Biotherapeutics